Phenytoin-induced extrapontine myelinolysis;Reversible phenytoin-induzierte extrapontine myelinolyse

Nervenarzt

Volumn 72, Issue 6, 2001, Pages 453-455

  Behrens, S ^a   Pohlmann Eden, S ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Epilepsy; MRI; Phenytoin Extrapontine myelinolysis

Indexed keywords

LAMOTRIGINE; PHENOBARBITAL; PHENYTOIN; VALPROIC ACID; VIGABATRIN;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; CONTRAST ENHANCEMENT; DEMYELINATING DISEASE; DISEASE ASSOCIATION; FEMALE; FOCAL EPILEPSY; FOLLOW UP; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PONS; SEIZURE; CENTRAL PONTINE MYELINOLYSIS; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; EPILEPSY; PATHOLOGY; REMISSION;

ADULT; EPILEPSY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MAGNETIC RESONANCE IMAGING; MYELINOLYSIS, CENTRAL PONTINE; PHENYTOIN; PONS; REMISSION, SPONTANEOUS;

EID: 0034743761     PISSN: 00282804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001150050779     Document Type: Article

References (7)

1. Marchiafava-Bignami disease with recovery diagnosed by CT and MRI: Demyelination affects several CNS structures
2. MR imaging evaluation of seizures
3. MRI findings in epileptic patients on vigabatrin for more than 5 years
4. Marchiafava-Bignami disease: Reversibility of neuroimaging abnormality
5. Vigabatrin, a gabaergic antiepileptic drug, causes concentric visual field defects
6. Focal lesion in the splenium of the corpus callosum in epileptic patients: Antiepileptic drug toxicity?
7. Pontine and extrapontine myelinolysis